2023-02-13T22:23:09+03:00[Europe/Moscow] en true <p>1st order</p>, <p>constant</p>, <p>proportional</p>, <p>constant </p>, <p>a</p>, <p>b</p>, <p>b</p>, <p>b</p>, <p>saturable</p>, <p>increase</p>, <p>increase</p>, <p>saturable</p>, <p>decreased</p>, <p>increased</p>, <p>1.45L/min</p>, <p>proportional</p>, <p>insensitive</p>, <p>proportional</p>, <p>insensitive</p>, <p>little secretion or reabsorption</p>, <p>net tubular secretion occurred</p>, <p>net tubular absorption occurred</p>, <p>glomerulus</p>, <p>proximal tubule </p>, <p>distal convoluted tubule</p>, <p>a</p>, <p>b</p>, <p>b,c</p>, <p>a</p>, <p>c</p>, <p>either</p>, <p>weak acids or weak bases</p>, <p>nonionized; ionized remains in urine</p>, <p>secretion; reabsorption</p>, <p>F</p>, <p>d</p>, <p>F</p>, <p>F</p>, <p>systemic circulation</p>, <p>hepatic artery &amp; portal vein</p>, <p>excretion rate</p>, <p>renal &amp; billiary </p> flashcards
Ceutics Concept Questions Test.1

Ceutics Concept Questions Test.1

  • 1st order

    ADME follows ________ kinetics.

  • constant

    In first order kinetics, Elimination rate constant (k), half-life (t1/2), apparent volume of distribution (V), and clearance remain _______.

  • proportional

    In First order kinetics, Increase in the dose causes _________ increase in plasma drug concentration and AUC0-00.

  • constant

    In First order kinetics, concentrations of the drugs in plasma are below protein binding saturation, fp remains _______.

  • a

    Dose-independant

    a) linear PK

    b) Nonlinear PK

  • b

    Dose-dependent

    a) linear PK

    b) Nonlinear PK

  • b

    AUC0-00 is disproportional to the dose.

    a) linear PK

    b) Nonlinear PK

  • b

    >=1 of ADME processes is saturable.

    a) linear PK

    b) Nonlinear PK

  • saturable

    Drug-plasma protein binding is _______.

  • increase

    Increased fp my cause _____ in CLH and/or CLR

  • increase

    Increased fp may cause _____ in V.

  • saturable

    Renal Secretion and active renal reabsorption are ______ processes.

  • decreased

    Saturated tubular secretion will lead to ______ CLR

  • increased

    Saturated tubular reabsorption leads to ______ CLR

  • 1.45L/min

    What is Qh or hepatic blood flow?

  • proportional

    When EH > 0.8, CLH is _______ to the change in QH.

  • insensitive

    When EH> 0.8, CLH is _______ to the change in fp or CLint.

  • proportional

    When EH<0.2, CLH is ________ to the change in fp or CLint

  • insensitive

    When EH <0.2, CLH is _______ to the change in QH.

  • little secretion or reabsorption

    CLR= fp*GFR

  • net tubular secretion occurred

    CLR> fp* GFR

  • net tubular absorption occurred

    CLR< fp * GFR

  • glomerulus

    Filtration occurs in the _______ of the nephron.

  • proximal tubule

    Secretion occurs in the ______ of the nephron.

  • distal convoluted tubule

    Absorption occurs in the ______ of the nephron.

  • a

    Which process is influenced by Protein binding?

    a) filtration

    b) secretion

    c) absorption

  • b

    Which process is influenced by competitive inhibitors?

    a) filtration

    b) secretion

    c) absorption

  • b,c

    Which process is active?

    a) filtration

    b) secretion

    c) absorption

  • a

    Which process is passive?

    a) filtration

    b) secretion

    c) absorption

  • c

    Which process is influenced by urinary pH and flow?

    a) filtration

    b) secretion

    c) absorption

  • either

    What kind of drug ionization is a characteristic of filtration?

  • weak acids or weak bases

    What kind of drug ionization is a characteristic of secretion?

  • nonionized; ionized remains in urine

    What kind of drug ionization is a characteristic of reabsorption?

  • secretion; reabsorption

    Tubular______ and _______ are independent of plasma protein binding.

  • F

    The elimination rate constant should be larger than the absorption rate constant. T/F?

  • d

    The extent of oral absorption depends on____________.

    a) dissolution of the dosage form

    b) drug metabolism in the GI tract/liver

    c) nature of the drug

    d) all of the above

  • F

    The oral bioavailability can be any number greater than 0. T/F?

  • F

    Variability in Vmax and Km values in patients causes a narrow range in the effective doses needed to achieve therapeutic levels. T/F?

  • systemic circulation

    Significant first-pass metabolism means that much of the drug's metabolism occurs before its arrival at the _________.

  • hepatic artery & portal vein

    The liver receive(s) blood from the ___________.

  • excretion rate

    Renal clearance can be calculated from what ratio of rates to the drugs concentration in plasma?

  • renal & billiary

    Two important routes of drug excretion are _______.